By Jill Redhage
Daily Journal Staff Writer
Back in 2008, two California law firms squelched Roche Holding's surprise offer to buy out Bay Area biotechnology company Genentech Inc. for $43.7 billion. That year, Wilson Sonsini Goodrich & Rosati lawyers advised Genentech and its board of directors and Latham & Watkins attorneys counseled a special committee of the board to dismiss the Swiss pharmaceutical company's unsolicited o...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In